Nexien BioPharma Inc (NXEN)

[Renegades17]

Really need to ramp up the IR effort

Mark is generally responsive, but they need to issue a PR highlighting the strategy and achievements from the 10-K. It appears that there were multiple patent filings, but I only say one PR back in the early Summer.

Compared to other CBD drug stocks this stock is grossly undervalued. Perhaps they are waiting for a PR blitz after getting listed on CSE, but I think they are missing out on a great opportunity to capitalize on sector momentum now.

The float is still super thin, so some positive buzz would do wonders to lift the stock.

If anyone has a good connection with Mark, please try to push him towards another corporate "summary" PR.